Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

427754

registered interest
date	10/11/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Exercise
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he plans to take to fully integrate physical activity into the care pathways of all long-term conditions where it has a proven beneficial effect.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	15984
answer	answer is ministerial correction date of answer 17/11/2015 answer text <p>The National Institute for Health and Care Excellence (NICE) has published various pieces of guidance covering long-term conditions, and this guidance promotes physical activity where is it shown to have a beneficial effect.</p><br /><p>In addition to this, Public Health England (PHE) has highlighted the important role of physical activity in the prevention, treatment and management of many long-term conditions in Everybody Active Every Day, a national evidence-based framework for action to reduce inactivity in England launched in 2014.</p><br /><p>Since then there has been sustained action to support the integration of physical activity into clinical practice.</p><br /><p>This has included:</p><br /><p>- The launch of a new set of teaching resources designed to integrating into the curriculum on physical activity for medical, nursing and allied health professional university departments. To date these have been taken up by 15 United Kingdom medical schools, 4 UK Schools of Health (dietetics/physio/OT and AHPs) and 5 international schools of Allied Health Professionals;</p><p>- The launch of a series of nine e-learning modules on physical activity in the treatment and prevention of long term conditions on the BMJ E-learning platform alongside e-learning on Motivational interviewing techniques, funded by PHE;</p><p>- The launch of a new info-graphic to support healthcare professionals to understand and put into practice the Chief Medical Officer’s guidelines on physical activity for adults, a further graphic is in development to support the guidelines for children and young people;</p><p>- An expanded pilot of the general practitioner clinical champion programme by PHE;</p><p>- Continued work with the Richmond group of charities who are building on the work of Macmillan and Breakthrough Breast Cancer to support integration of physical activity into clinical practice and care pathways and also raise the understanding amongst the third sector and wider communities of its important role; and</p><p>- Continued work with the Academy of Medical Royal Colleges, Chartered Institute of Physiotherapists and other professional bodies to raise the awareness across the profession, and ensuring that physical activity is considered as a key part of the Making Every Contact Count approach across health and social care.</p><br /><p>Further work is being considered for 2016/17 around how better to support the commissioning of evidence-based exercise referral programmes for specific conditions as recommended by NICE.</p><br /> <br /> <br /> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/11/2015 16:23:10 answering member 3918 label Biography information for Jane Ellison
tabling member	4122 label Biography information for Alex Cunningham

228589

registered interest
date	19/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Alcoholic Drinks: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate he has made of the cost to the economy of alcohol-related harm in the last year.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	228427
answer	answer is ministerial correction date of answer 24/03/2015 answer text <p>Alcohol-related harm was estimated to cost the United Kingdom economy £7.3 billion for 2009-10. Work is ongoing to produce estimates for more recent years.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 24/03/2015 17:32:42 answering member 3918 label Biography information for Jane Ellison
tabling member	4122 label Biography information for Alex Cunningham

178519

registered interest
date	09/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Alcoholic Drinks: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate he has made of the cost to the NHS of alcohol-related harm in each of the last 10 years.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	223833
answer	answer is ministerial correction date of answer 24/02/2015 answer text <p>Estimates have been made of the cost to the National Health Service of alcohol related harm at around £2.7 billion per year in 2006-07 and £3.5 billion per year in 2009-10.</p><p> </p><p> </p><p> </p><p>Work is ongoing to produce estimates for more recent years.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 24/02/2015 17:30:05 answering member 3918 label Biography information for Jane Ellison
tabling member	4122 label Biography information for Alex Cunningham

78189

registered interest
date	15/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Older People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what research (a) his Department and (b) NHS England is undertaking into comparative cancer survival rates for older people in the UK and other European countries.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	205945
answer	answer is ministerial correction date of answer 21/07/2014 answer text <p>NHS England has undertaken some initial analysis of the causes of poorer survival rates in older people. This suggests that several issues contribute to poorer survival in older adults. These include the fact that the chances of diagnosis at emergency presentation increase with age and that older patients are more likely to have co-morbidity which may impact on survival during and after surgery. There is also some evidence that access to surgery, chemotherapy and radiotherapy for older patients has historically been worse than for younger patients. Previous work by the National Cancer Equality Initiative and the National Cancer Information Network has identified that cancer treatment rates decline with age.</p><p> </p><p>The International Cancer Benchmarking Partnership has sought to understand how and why cancer survival varies between countries, including among older people. The partnership has generated insight and understanding that will help all partners improve cancer survival outcomes by optimising cancer policies and services.</p><p> </p><p>Evidence from this initiative suggests that late diagnosis and treatment are crucial factors in England having lower survival rates than other comparable countries (i.e. countries with good data collection systems and similar levels of development). We also know that the most important reasons for late diagnosis are low awareness of the signs and symptoms of cancer; and delays in patients presenting to their doctors.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/07/2014 16:25:08 answering member 3918 label Biography information for Jane Ellison
tabling member	4122 label Biography information for Alex Cunningham

77416

registered interest
date	11/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Idiopathic Pulmonary Fibrosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to reduce deaths from idiopathic pulmonary fibrosis.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	205399
answer	answer is ministerial correction date of answer 21/07/2014 answer text <p>Reducing mortality and improving outcomes for people with respiratory disease is a key priority for this Government. It is specifically covered in both the Public Health and NHS Outcome Frameworks. NHS England is working to improve the quality of NHS services, and will be held to account through the Mandate.</p><p> </p><p>The responsibility for the commissioning of services for interstitial lung disease (ILD) sits under the umbrella of specialised commissioning within NHS England. It has published a service specification for ILD at:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/a14-respiratory-inters-lung.pdf</p><p> </p><p>Pages 3 and 4 of this specification set out the overall aim of the specialist service and how a standardised approach to treatment across the country should be delivered.</p><p> </p><p>In line with the implementation of all specialised commissioning specifications, NHS England is undertaking a compliance programme assessing all current providers of ILD services against a set of key requirements from the specification.</p><p> </p><p>Area Teams are now working with providers to commission the services and once arrangements have been agreed then the list of ILD centres will be made public. We expect this exercise to be completed later in the year.</p><p> </p><p>In April 2013, the National Institute of Health and Care Excellence (NICE) published a technology appraisal advising on the use of Pirfenidone as a treatment for idiopathic pulmonary fibrosis (IPF). In June 2013, NICE published its first clinical guideline on the diagnosis and management of IPF. The use of other treatments for the management of ILD are also covered by the NICE guidelines. We expect commissioners to have regard to NICE guidelines when commissioning services.</p><p> </p><p>NHS England funds the treatment of patients with Pirfenidone, in line with the NICE appraisal, from centres that are contracted to provide specialised services for patients with ILD.</p><p> </p><p>There were no awareness raising campaigns specifically targeted at IFP in the specified timeframe. Though IPF was not directly referenced, Public Health England recently ran a local pilot campaign in Oldham and Rochdale to raise awareness amongst the public about the importance of visiting their general practitioner with symptoms of breathlessness.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 205400 205401 205402 question first answered 21/07/2014 16:13:34 answering member 3918 label Biography information for Jane Ellison
tabling member	4122 label Biography information for Alex Cunningham

77418

registered interest
date	11/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Idiopathic Pulmonary Fibrosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department plans to take to ensure that the 2013 idiopathic pulmonary fibrosis guidelines, drawn up by the National Institute for Health and Care Excellence, are fully implemented.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	205400
answer	answer is ministerial correction date of answer 21/07/2014 answer text <p>Reducing mortality and improving outcomes for people with respiratory disease is a key priority for this Government. It is specifically covered in both the Public Health and NHS Outcome Frameworks. NHS England is working to improve the quality of NHS services, and will be held to account through the Mandate.</p><p> </p><p>The responsibility for the commissioning of services for interstitial lung disease (ILD) sits under the umbrella of specialised commissioning within NHS England. It has published a service specification for ILD at:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/a14-respiratory-inters-lung.pdf</p><p> </p><p>Pages 3 and 4 of this specification set out the overall aim of the specialist service and how a standardised approach to treatment across the country should be delivered.</p><p> </p><p>In line with the implementation of all specialised commissioning specifications, NHS England is undertaking a compliance programme assessing all current providers of ILD services against a set of key requirements from the specification.</p><p> </p><p>Area Teams are now working with providers to commission the services and once arrangements have been agreed then the list of ILD centres will be made public. We expect this exercise to be completed later in the year.</p><p> </p><p>In April 2013, the National Institute of Health and Care Excellence (NICE) published a technology appraisal advising on the use of Pirfenidone as a treatment for idiopathic pulmonary fibrosis (IPF). In June 2013, NICE published its first clinical guideline on the diagnosis and management of IPF. The use of other treatments for the management of ILD are also covered by the NICE guidelines. We expect commissioners to have regard to NICE guidelines when commissioning services.</p><p> </p><p>NHS England funds the treatment of patients with Pirfenidone, in line with the NICE appraisal, from centres that are contracted to provide specialised services for patients with ILD.</p><p> </p><p>There were no awareness raising campaigns specifically targeted at IFP in the specified timeframe. Though IPF was not directly referenced, Public Health England recently ran a local pilot campaign in Oldham and Rochdale to raise awareness amongst the public about the importance of visiting their general practitioner with symptoms of breathlessness.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 205399 205401 205402 question first answered 21/07/2014 16:13:34 answering member 3918 label Biography information for Jane Ellison
tabling member	4122 label Biography information for Alex Cunningham

77419

registered interest
date	11/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Idiopathic Pulmonary Fibrosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much funding his Department provided for awareness-raising work for idiopathic pulmonary fibrosis in (a) 2011, (b) 2012 and (c) 2013.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	205401
answer	answer is ministerial correction date of answer 21/07/2014 answer text <p>Reducing mortality and improving outcomes for people with respiratory disease is a key priority for this Government. It is specifically covered in both the Public Health and NHS Outcome Frameworks. NHS England is working to improve the quality of NHS services, and will be held to account through the Mandate.</p><p> </p><p>The responsibility for the commissioning of services for interstitial lung disease (ILD) sits under the umbrella of specialised commissioning within NHS England. It has published a service specification for ILD at:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/a14-respiratory-inters-lung.pdf</p><p> </p><p>Pages 3 and 4 of this specification set out the overall aim of the specialist service and how a standardised approach to treatment across the country should be delivered.</p><p> </p><p>In line with the implementation of all specialised commissioning specifications, NHS England is undertaking a compliance programme assessing all current providers of ILD services against a set of key requirements from the specification.</p><p> </p><p>Area Teams are now working with providers to commission the services and once arrangements have been agreed then the list of ILD centres will be made public. We expect this exercise to be completed later in the year.</p><p> </p><p>In April 2013, the National Institute of Health and Care Excellence (NICE) published a technology appraisal advising on the use of Pirfenidone as a treatment for idiopathic pulmonary fibrosis (IPF). In June 2013, NICE published its first clinical guideline on the diagnosis and management of IPF. The use of other treatments for the management of ILD are also covered by the NICE guidelines. We expect commissioners to have regard to NICE guidelines when commissioning services.</p><p> </p><p>NHS England funds the treatment of patients with Pirfenidone, in line with the NICE appraisal, from centres that are contracted to provide specialised services for patients with ILD.</p><p> </p><p>There were no awareness raising campaigns specifically targeted at IFP in the specified timeframe. Though IPF was not directly referenced, Public Health England recently ran a local pilot campaign in Oldham and Rochdale to raise awareness amongst the public about the importance of visiting their general practitioner with symptoms of breathlessness.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 205399 205400 205402 question first answered 21/07/2014 16:13:34 answering member 3918 label Biography information for Jane Ellison
tabling member	4122 label Biography information for Alex Cunningham

77421

registered interest
date	11/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Idiopathic Pulmonary Fibrosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when the allocation of interstitial lung disease specialist centres will be completed; and when his Department will publish the location of these centres.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	205402
answer	answer is ministerial correction date of answer 21/07/2014 answer text <p>Reducing mortality and improving outcomes for people with respiratory disease is a key priority for this Government. It is specifically covered in both the Public Health and NHS Outcome Frameworks. NHS England is working to improve the quality of NHS services, and will be held to account through the Mandate.</p><p> </p><p>The responsibility for the commissioning of services for interstitial lung disease (ILD) sits under the umbrella of specialised commissioning within NHS England. It has published a service specification for ILD at:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/a14-respiratory-inters-lung.pdf</p><p> </p><p>Pages 3 and 4 of this specification set out the overall aim of the specialist service and how a standardised approach to treatment across the country should be delivered.</p><p> </p><p>In line with the implementation of all specialised commissioning specifications, NHS England is undertaking a compliance programme assessing all current providers of ILD services against a set of key requirements from the specification.</p><p> </p><p>Area Teams are now working with providers to commission the services and once arrangements have been agreed then the list of ILD centres will be made public. We expect this exercise to be completed later in the year.</p><p> </p><p>In April 2013, the National Institute of Health and Care Excellence (NICE) published a technology appraisal advising on the use of Pirfenidone as a treatment for idiopathic pulmonary fibrosis (IPF). In June 2013, NICE published its first clinical guideline on the diagnosis and management of IPF. The use of other treatments for the management of ILD are also covered by the NICE guidelines. We expect commissioners to have regard to NICE guidelines when commissioning services.</p><p> </p><p>NHS England funds the treatment of patients with Pirfenidone, in line with the NICE appraisal, from centres that are contracted to provide specialised services for patients with ILD.</p><p> </p><p>There were no awareness raising campaigns specifically targeted at IFP in the specified timeframe. Though IPF was not directly referenced, Public Health England recently ran a local pilot campaign in Oldham and Rochdale to raise awareness amongst the public about the importance of visiting their general practitioner with symptoms of breathlessness.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 205399 205400 205401 question first answered 21/07/2014 16:13:34 answering member 3918 label Biography information for Jane Ellison
tabling member	4122 label Biography information for Alex Cunningham

65722

registered interest
date	03/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Motor Vehicles: Smoking
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 30 June 2014, Official Report, column 504W, on tobacco packaging, whether he plans to publish draft regulations to outlaw smoking in cars with children present in time for them to be made law before the end of March 2015.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	203950
answer	answer is ministerial correction date of answer 08/07/2014 answer text <p>As set out in my previous answer of 30 June 2014, <em>Official Report</em>, column 504W, regulations for making it an offence to smoke in private vehicles carrying children are being drafted at present.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 08/07/2014 15:54:31 answering member 3918 label Biography information for Jane Ellison
tabling member	4122 label Biography information for Alex Cunningham

63912

registered interest
date	25/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Accident and Emergency Departments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the (a) mean and (b) median duration to assessment, duration to treatment and duration to departure was in (i) type 1 and (ii) all accident and emergency departments in each month in each of the last five years.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	202302
answer	answer is ministerial correction date of answer 30/06/2014 answer text <p>The information has been placed in the Library.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 30/06/2014 16:06:48 answering member 3918 label Biography information for Jane Ellison attachment 1 file name PQ202302 - Lib Doc - Table.xlsx title Library Document
tabling member	4122 label Biography information for Alex Cunningham